Hydromorphone 80 mg/ml + Fentanyl 15,000 mcg/ml + Bupivacaine 30 mg/ml Intrathecal Solution, The Compounding Pharmacy of America, Knoxville, TN
Published September 23, 2015 · Recall initiated: June 2, 2015
Summary
FDA records drug Class II recall D-1731-2015, published September 23, 2015 and initiated June 2, 2015. Recalling firm: The Compounding Pharmacy of America; Status: Terminated; Reported quantity: 70 ml; Lot: All lots distributed between November 2014 and May 2015; 03022015@6, 5/31/2015; 04172015@25, 6/16/2015; 05082015@35, 7/7/2015. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
What to do
Voluntary: Firm initiated · Telephone
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- The Compounding Pharmacy of America
- Distributor
- Nationwide
- Lot
- All lots distributed between November 2014 and May 2015; 03022015@6, 5/31/2015; 04172015@25, 6/16/2015; 05082015@35, 7/7/2015
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAHCG 5,000 IU/mL + Methylcobalamin 500 mcg/mL Injection 5 mL, Multi-Dose Vial, Sterile, Rx Only, Compounded byFebruary 21, 2018
- FDAHCG 1,250 IU/ml Injection, Multi-Dose Vial, Sterile, Refrigerate The Compounding Pharmacy of America,September 23, 2015
- FDAHydromorphone 30 mg/ml Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxville, TNSeptember 23, 2015
- FDATestosterone 20 mg, Sterile Pellet, The Compounding Pharmacy of America, Knoxville, TNSeptember 23, 2015
- FDAHydromorphone 70 mg/ml+Fentanyl 16,000 mcg/ml+Bupivacaine 15 mg/ml+Clonidine 1,000 mcg/ml+Baclofen 900 mcg/mlSeptember 23, 2015
- FDAHydromorphone 80 mg/ml + Fentanyl 15,000 mcg/ml + Bupivacaine 30 mg/ml + Baclofen 750 mcg/ml IntrathecalSeptember 23, 2015
Questions about this recall
Was Hydromorphone 80 mg/ml + Fentanyl 15,000 mcg/ml + Bupivacaine 30 mg/ml Intrathecal Solution, The Compounding Pharmacy of America, Knoxville, TN recalled?
Yes. FDA published recall D-1731-2015 on September 23, 2015. Reported hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
What should I do if I have this product?
Voluntary: Firm initiated · Telephone